{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T16:25:24Z","timestamp":1787329524604,"version":"build-2736575974"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-026-03390-5","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T15:21:09Z","timestamp":1787325669000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Revisiting clinical scoring tools for the diagnosis of thrombotic thrombocytopenic purpura (TTP)"],"prefix":"10.1007","author":[{"given":"Shruti","family":"Kharat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrimati","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maushmi S.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"issue":"8","key":"3390_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1056\/NEJMra020528","volume":"347","author":"JL Moake","year":"2002","unstructured":"Moake JL (2002) Thrombotic microangiopathies. N Engl J Med 347(8):589\u2013600. https:\/\/doi.org\/10.1056\/NEJMra020528","journal-title":"N Engl J Med"},{"issue":"1","key":"3390_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12185-009-0476-1","volume":"91","author":"HM Tsai","year":"2010","unstructured":"Tsai HM (2010) Pathophysiology of thrombotic thrombocytopenic purpura. Int J Hematol 91(1):1\u201319. https:\/\/doi.org\/10.1007\/s12185-009-0476-1","journal-title":"Int J Hematol"},{"issue":"1","key":"3390_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1182\/blood-2008-02-078170","volume":"112","author":"JE Sadler","year":"2008","unstructured":"Sadler JE (2008) Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood 112(1):11\u201318","journal-title":"Blood"},{"issue":"6","key":"3390_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJM199108083250604","volume":"325","author":"GA Rock","year":"1991","unstructured":"Rock GA, Shumak KH, Buskard et al (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpur Canadian apheresis study group. New England J Med 325(6):393\u2013397. https:\/\/doi.org\/10.1056\/NEJM199108083250604","journal-title":"New England J Med"},{"issue":"5","key":"3390_CR5","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/j.1365-2141.2008.07276","volume":"142","author":"M Scully","year":"2008","unstructured":"Scully M, Yarranton H et al (2008) Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features. Br J Haematol 142(5):819\u2013826. https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07276","journal-title":"Br J Haematol"},{"issue":"7","key":"3390_CR6","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s00134-025-07981-3","volume":"51","author":"E Azoulay","year":"2025","unstructured":"Azoulay E, Veyradier A et al (2025) Thrombotic thrombocytopenic purpura: early diagnosis and effective treatment in 2025. Intensive Care Med 51(7):1225\u20131239. https:\/\/doi.org\/10.1007\/s00134-025-07981-3","journal-title":"Intensive Care Med"},{"key":"3390_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103168","volume":"82","author":"P Coppo","year":"2025","unstructured":"Coppo P, Bubenheim M et al (2025) Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective cohort study (The Capla 1000+ project). EClinicalMedicine 82:103168. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103168","journal-title":"EClinicalMedicine"},{"issue":"21","key":"3390_CR8","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","volume":"129","author":"BS Joly","year":"2017","unstructured":"Joly BS, Coppo P, Veyradier A (2017) Thrombotic thrombocytopenic purpura. Blood 129(21):2836\u20132846. https:\/\/doi.org\/10.1182\/blood-2016-10-709857","journal-title":"Blood"},{"issue":"19","key":"3390_CR9","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1182\/blood-2017-06-788026","volume":"130","author":"M Scully","year":"2017","unstructured":"Scully M, Kn\u00f6bl P et al (2017) Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura. Blood 130(19):2055\u20132063. https:\/\/doi.org\/10.1182\/blood-2017-06-788026","journal-title":"Blood"},{"key":"3390_CR10","doi-asserted-by":"publisher","unstructured":"Moore GW, Llusa M, Griffiths M, Binder NB (2023). ADAMTS13 Activity Measurement by ELISA and Fluorescence Resonance Energy Transfer Assay. In: Favaloro, E.J., Gosselin, R.C. (eds) Hemostasis and Thrombosis. Methods in Molecular Biology, vol 2663. Humana, New York, NY. https:\/\/doi.org\/10.1007\/978-1-0716-3175-1_35.","DOI":"10.1007\/978-1-0716-3175-1_35"},{"issue":"1","key":"3390_CR11","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1182\/asheducation-2018.1.530","volume":"2018","author":"T Chiasakul","year":"2018","unstructured":"Chiasakul T, Cuker A (2018) Clinical and laboratory diagnosis of TTP: an integrated approach. Hematology Am Soc Hematol Educ Program 2018(1):530\u2013538. https:\/\/doi.org\/10.1182\/asheducation-2018.1.530","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"3390_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(16)30018-7","author":"P perez","year":"2016","unstructured":"perez P (2016) Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy. Lancet Haematol. https:\/\/doi.org\/10.1016\/S2352-3026(16)30018-7","journal-title":"Lancet Haematol"},{"issue":"18","key":"3390_CR13","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1056\/NEJMcp053024","volume":"354","author":"JN George","year":"2006","unstructured":"George JN (2006) Clinical practice thrombotic thrombocytopenic purpura. New England J Med 354(18):1927\u20131935. https:\/\/doi.org\/10.1056\/NEJMcp053024","journal-title":"New England J Med"},{"issue":"9","key":"3390_CR14","first-page":"005628","volume":"12","author":"K Takamatsu","year":"2025","unstructured":"Takamatsu K, Wannaphut C, Benavente K, Nishimura Y, Chong C (2025) A clever stroke mimic: thrombotic thrombocytopenic purpura without schistocytes a case report and literature review. European J Case Rep Internal Med 12(9):005628","journal-title":"European J Case Rep Internal Med"},{"key":"3390_CR15","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1751-553X.2011.01380.x","volume":"34","author":"G Zini","year":"2012","unstructured":"Zini G, d\u2019Onofrio G, Briggs C, Erber W, Jou JM, Lee SH et al (2012) ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes. Int J Lab Hematol 34:107\u2013116","journal-title":"Int J Lab Hematol"},{"key":"3390_CR16","doi-asserted-by":"publisher","unstructured":". Inamoto, Y., Ito, M., et.al. Blood and Marrow Transplantation Group (2009). Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy.\u00a0Bone marrow transplantation,\u00a044(1), 43\u201349. https:\/\/doi.org\/10.1038\/bmt.2008.419","DOI":"10.1038\/bmt.2008.419"},{"issue":"9","key":"3390_CR17","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/ajh.22091","volume":"86","author":"KK Booth","year":"2011","unstructured":"Booth KK, Terrell DR, Vesely SK, George JN (2011) Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol 86(9):743\u2013751. https:\/\/doi.org\/10.1002\/ajh.22091","journal-title":"Am J Hematol"},{"issue":"7","key":"3390_CR18","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1056\/NEJMra1312353","volume":"371","author":"JN George","year":"2014","unstructured":"George JN, Nester CM (2014) Syndromes of thrombotic microangiopathy. N Engl J Med 371(7):654\u2013666. https:\/\/doi.org\/10.1056\/NEJMra1312353","journal-title":"N Engl J Med"},{"issue":"6","key":"3390_CR19","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","volume":"118","author":"BL Laskin","year":"2011","unstructured":"Laskin BL, Goebel J, Davies SM, Jodele S (2011) Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood 118(6):1452\u20131462. https:\/\/doi.org\/10.1182\/blood-2011-02-321315","journal-title":"Blood"},{"key":"3390_CR20","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.2147\/IMCRJ.S536982","volume":"18","author":"C Wang","year":"2025","unstructured":"Wang C, Kong M, Huang M, Tang N, Mo H (2025) Severe Plasmodium falciparum malaria mimicking thrombotic thrombocytopenic purpura (TTP): a case report from China. Int Med Case Rep J 18:1029\u20131034. https:\/\/doi.org\/10.2147\/IMCRJ.S536982","journal-title":"Int Med Case Rep J"},{"issue":"4","key":"3390_CR21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.4103\/ijccm.IJCCM_27_16","volume":"21","author":"AS Gavali","year":"2017","unstructured":"Gavali AS, Shelgaonkar J, Bartakke S (2017) Thrombotic thrombocytopenic purpura in a case of dengue fever: a rare presentation. Indian J Critical Care Med\u202f: Peer-rev, official Publi Indian Soc Critical Care Med 21(4):226\u2013228. https:\/\/doi.org\/10.4103\/ijccm.IJCCM_27_16","journal-title":"Indian J Critical Care Med : Peer-rev, official Publi Indian Soc Critical Care Med"},{"key":"3390_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2147\/CPAA.S207258","volume":"11","author":"Y Fahmawi","year":"2019","unstructured":"Fahmawi Y, Campos, et al (2019) Vitamin B12 deficiency presenting as pseudo-thrombotic microangiopathy: a case report and literature review. Clinical Pharmacol\u202f: Adv appl 11:127\u2013131. https:\/\/doi.org\/10.2147\/CPAA.S207258","journal-title":"Clinical Pharmacol : Adv appl"},{"issue":"6","key":"3390_CR23","first-page":"120","volume":"8","author":"MJ Bentley","year":"2010","unstructured":"Bentley MJ, Wilson AR, Rodgers GM (2010) A clinical prediction score for thrombotic thrombocytopenic purpura. J Thromb Haemost 8(6):120\u2013128","journal-title":"J Thromb Haemost"},{"issue":"4","key":"3390_CR24","doi-asserted-by":"publisher","first-page":"e10208","DOI":"10.1371\/journal.pone.0010208","volume":"5","author":"P Coppo","year":"2010","unstructured":"Coppo P, Schwarzinger, et al (2010) French reference center for thrombotic microangiopathies predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience. PLoS ONE 5(4):e10208. https:\/\/doi.org\/10.1371\/journal.pone.0010208","journal-title":"PLoS ONE"},{"issue":"4","key":"3390_CR25","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1016\/S2352-3026(17)30026-1","volume":"4","author":"PK Bendapudi","year":"2017","unstructured":"Bendapudi PK, Hurwitz, et al (2017) Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study. The Lancet. Haematology 4(4):e157\u2013e164. https:\/\/doi.org\/10.1016\/S2352-3026(17)30026-1","journal-title":"The Lancet. Haematology"},{"key":"3390_CR26","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1111\/trf.15954","volume":"60","author":"K Paydary","year":"2020","unstructured":"Paydary K, Banwell E, Tong J, Chen Y, Cuker A (2020) Diagnostic accuracy of the PLASMIC score in patients with suspected thrombotic thrombocytopenic purpura: a systematic review and meta-analysis. Transfusion 60:2047\u20132057. https:\/\/doi.org\/10.1111\/trf.15954","journal-title":"Transfusion"},{"key":"3390_CR27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12882-025-04156-6","volume":"26","author":"MG Uriol-Rivera","year":"2025","unstructured":"Uriol-Rivera MG, Ernst FR, Booth JN et al (2025) PLASMIC score to aid diagnosis of aHUS: an analysis of C5 inhibitor clinical trials and the PINC AI\u2122 healthcare database. BMC Nephrol 26:241. https:\/\/doi.org\/10.1186\/s12882-025-04156-6","journal-title":"BMC Nephrol"},{"issue":"4","key":"3390_CR29","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2215\/CJN.11470918","volume":"14","author":"G Bayer","year":"2019","unstructured":"Bayer G, von Tokarski F et al (2019) Etiology and outcomes of thrombotic microangiopathies. Clin J Am Soc Nephrol 14(4):557\u2013566. https:\/\/doi.org\/10.2215\/CJN.11470918","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"3390_CR30","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/trf.16188","volume":"61","author":"A Liu","year":"2021","unstructured":"Liu A, Dhaliwal N, Upreti H et al (2021) Reduced sensitivity of PLASMIC and French scores for the diagnosis of thrombotic thrombocytopenic purpura in older individuals. Transfusion 61(1):266\u2013273. https:\/\/doi.org\/10.1111\/trf.16188","journal-title":"Transfusion"},{"issue":"1","key":"3390_CR31","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/trf.16188","volume":"61","author":"A Liu","year":"2021","unstructured":"Liu A, Dhaliwal N et al (2021) Reduced sensitivity of PLASMIC and French scores for the diagnosis of thrombotic thrombocytopenic purpura in older individuals. Transfusion 61(1):266\u2013273. https:\/\/doi.org\/10.1111\/trf.16188","journal-title":"Transfusion"},{"issue":"1","key":"3390_CR32","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/jth.13882","volume":"16","author":"A Li","year":"2018","unstructured":"Li A, Khalighi PR, Wu Q, Garcia DA (2018) External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment. J Thromb Haemost 16(1):164\u2013169. https:\/\/doi.org\/10.1111\/jth.13882","journal-title":"J Thromb Haemost"},{"issue":"2","key":"3390_CR33","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/bjh.15455","volume":"185","author":"RP Jajosky","year":"2019","unstructured":"Jajosky RP, George JN (2019) Performance of the PLASMIC score in unselected patients with thrombotic microangiopathy. Br J Haematol 185(2):342\u2013344","journal-title":"Br J Haematol"},{"key":"3390_CR34","doi-asserted-by":"crossref","first-page":"107602962110123","DOI":"10.1177\/1076029621996810","volume":"27","author":"L Tang","year":"2021","unstructured":"Tang L, Chen X, Zhao Y, Li J, Wang X (2021) Evaluation of mean corpuscular volume as a predictor of thrombotic thrombocytopenic purpura. Clin Appl Thromb Hemost 27:10760296211012344","journal-title":"Clin Appl Thromb Hemost"},{"issue":"9","key":"3390_CR35","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/jth.14964","volume":"18","author":"YC Lin","year":"2020","unstructured":"Lin YC, Chang HH, Chen YC, Wu JH, Huang CC (2020) Modified PLASMIC score improves prediction of severe ADAMTS13 deficiency in Taiwanese patients. J Thromb Haemost 18(9):2318\u20132326","journal-title":"J Thromb Haemost"},{"issue":"4","key":"3390_CR36","first-page":"843","volume":"102","author":"X Chen","year":"2023","unstructured":"Chen X, Li Y, Zhao Y, Wang J (2023) Reevaluation of haematologic indices in the diagnosis of thrombotic thrombocytopenic purpura. Ann Hematol 102(4):843\u2013851","journal-title":"Ann Hematol"},{"key":"3390_CR37","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ekir.2021.11.009","volume":"7","author":"N Fage","year":"2021","unstructured":"Fage N, Orvain C, Henry N (2021) Proteinuria increases the PLASMIC and French scores performance to predict thrombotic thrombocytopenic purpura in patients with thrombotic microangiopathy syndrome. Kidney Int Rep 7:221\u2013231","journal-title":"Kidney Int Rep"},{"key":"3390_CR38","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/jca.21760","volume":"35","author":"N Zhao","year":"2020","unstructured":"Zhao N, Zhou L, Hu X et al (2020) A modified PLASMIC score including the lactate dehydrogenase\/the upper limit of normal ratio more accurately identifies Chinese thrombotic thrombocytopenic purpura patients than the original PLASMIC score. J Clin Apher 35:79\u201385. https:\/\/doi.org\/10.1002\/jca.21760","journal-title":"J Clin Apher"},{"issue":"6","key":"3390_CR39","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1007\/s00277-025-06472-1","volume":"104","author":"X Chen","year":"2025","unstructured":"Chen X, Zhang J, Fu J, Lin X, Li W, Wu Z, Cai R, Wei L, Luo X (2025) A predictive algorithm involving lactate dehydrogenase to serum creatinine ratio may assist in identifying patients with thrombotic thrombocytopenic purpura. Ann Hematol 104(6):3165\u20133172. https:\/\/doi.org\/10.1007\/s00277-025-06472-1","journal-title":"Ann Hematol"},{"issue":"26","key":"3390_CR40","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1182\/blood.2020005395","volume":"135","author":"K Sakai","year":"2020","unstructured":"Sakai K, Kuwana M, Tanaka H et al (2020) HLA loci predisposing to immune TTP in Japanese: potential role of the shared ADAMTS13 peptide bound to different HLA-DR. Blood 135(26):2413\u20132419","journal-title":"Blood"},{"issue":"2","key":"3390_CR41","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.humimm.2016.11.005","volume":"78","author":"G Sinkovits","year":"2017","unstructured":"Sinkovits G, Szil\u2019agyi A, Farkas P et al (2017) The role of human leukocyte antigen DRB1-DQB1 haplotypes in the susceptibility to acquired idiopathic thrombotic thrombocytopenic purpura. Hum Immunol 78(2):80\u201387","journal-title":"Hum Immunol"},{"issue":"Suppl 5","key":"3390_CR42","doi-asserted-by":"publisher","first-page":"S170","DOI":"10.1016\/j.htct.2023.11.016","volume":"46","author":"S Pandey","year":"2024","unstructured":"Pandey S, Shrivastava A, Harville YI, Cottler-Fox M, Harville TO (2024) HLA-DR-DQ associations, combined with PLASMIC score, are reliable predictors of acquired thrombotic thrombocytopenic purpura (aTTP) and aid in differentiating aTTP from other thrombotic microangiopathies. Hematol Transfus Cell Ther 46(Suppl 5):S170\u2013S180","journal-title":"Hematol Transfus Cell Ther"},{"key":"3390_CR43","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.thromres.2020.09.012","volume":"196","author":"C Wynick","year":"2020","unstructured":"Wynick C, Britto J, Sawler D, Parker A, Karkhaneh M, Goodyear MD, Sun HL (2020) Validation of the PLASMIC score for predicting ADAMTS13 activity <10% in patients with suspected thrombotic thrombocytopenic purpura in Alberta. Canada Thromb Res 196:335\u2013339. https:\/\/doi.org\/10.1016\/j.thromres.2020.09.012","journal-title":"Canada Thromb Res"},{"issue":"20","key":"3390_CR44","first-page":"3128","volume":"3","author":"B Baysal","year":"2019","unstructured":"Baysal B, Yardimci AC, Karahan S, Haznedaroglu IC, Ozcebe OI (2019) Comparison of PLASMIC and French scoring systems for predicting severe ADAMTS13 deficiency in elderly patients with suspected TTP. Blood Adv 3(20):3128\u20133136","journal-title":"Blood Adv"},{"issue":"26","key":"3390_CR45","first-page":"2545","volume":"1","author":"A Liu","year":"2017","unstructured":"Liu A, Chaturvedi S, Cataland SR, Wu HM (2017) Impact of age and clinical variables on the performance of the PLASMIC and French scores in predicting severe ADAMTS13 deficiency. Blood Adv 1(26):2545\u20132551","journal-title":"Blood Adv"},{"issue":"1","key":"3390_CR46","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12882-025-04156-6","volume":"26","author":"MG Uriol-Rivera","year":"2025","unstructured":"Uriol-Rivera MG, Ernst FR, Booth JN 3rd et al (2025) PLASMIC score to aid diagnosis of aHUS: an analysis of C5 inhibitor clinical trials and the PINC AI(TM) healthcare database. BMC Nephrol 26(1):241","journal-title":"BMC Nephrol"},{"key":"3390_CR47","doi-asserted-by":"publisher","first-page":"107602962312076","DOI":"10.1177\/10760296231207629","volume":"29","author":"N Nishimura","year":"2023","unstructured":"Nishimura N, Yoshimoto K, Yada N et al (2023) Combination of the LDH\/haemoglobin ratio with the PLASMIC score facilitates differentiation of TTP from septic DIC without schistocyte identification. Clin Appl Thromb Hemost 29:10760296231207628","journal-title":"Clin Appl Thromb Hemost"},{"issue":"5","key":"3390_CR48","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/jca.22068","volume":"38","author":"JA Lee","year":"2023","unstructured":"Lee JA, Lin MH, Kang CM et al (2023) Validation and modification of the PLASMIC score by adjusting MCV and INR criteria. J Clin Apher 38(5):582\u2013589","journal-title":"J Clin Apher"},{"issue":"5","key":"3390_CR49","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/jca.22067","volume":"38","author":"O Radhwi","year":"2023","unstructured":"Radhwi O, Badawi MA, Almarzouki A et al (2023) Saudi multicenter experience on therapeutic plasma exchange for TTP: a call for national registry. J Clin Apher 38(5):573\u2013581","journal-title":"J Clin Apher"},{"issue":"1","key":"3390_CR50","doi-asserted-by":"publisher","first-page":"36","DOI":"10.5045\/br.2023.2022133","volume":"58","author":"CCK Liam","year":"2023","unstructured":"Liam CCK, Tiao JY, Yap YY et al (2023) Validating lactate dehydrogenase as a component of the PLASMIC predictive tool (PLASMIC-LDH). Blood Res 58(1):36\u201341","journal-title":"Blood Res"},{"issue":"Suppl 1","key":"3390_CR51","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1182\/blood-2018-99-111416","volume":"132","author":"M Reddy","year":"2018","unstructured":"Reddy M, Sakurai S, Park S et al (2018) PLASMIC score in thrombotic microangiopathy may not be discriminatory in many instances. Blood 132(Suppl 1):2440 ((abstract))","journal-title":"Blood"},{"issue":"4","key":"3390_CR52","first-page":"345","volume":"21","author":"A Tufano","year":"2023","unstructured":"Tufano A, Polimeno M, Matani B et al (2023) Validation of PLASMIC score in a cohort of patients with suspected TMA. Blood Transfus 21(4):345\u2013349","journal-title":"Blood Transfus"},{"key":"3390_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.893273","volume":"9","author":"CH Lee","year":"2022","unstructured":"Lee CH, Huang YC, Li SS et al (2022) Application of PLASMIC score in risk prediction of TTP: real-world experience from a tertiary centre in Taiwan. Front Med (Lausanne) 9:893273","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"3390_CR54","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/1744-9987.13864","volume":"27","author":"J Tau","year":"2023","unstructured":"Tau J, Fernando LP, Munoz MC et al (2023) Evaluation of TTP and other TMAs: lessons from a 14-year retrospective study. Ther Apher Dial 27(1):136\u2013145","journal-title":"Ther Apher Dial"},{"issue":"6","key":"3390_CR55","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1093\/ajcp\/aqab078","volume":"156","author":"SD Martin","year":"2021","unstructured":"Martin SD, McGinnis E, Smith TW (2021) Indicators differentiating TTP from other TMAs in a Canadian apheresis referral centre. Am J Clin Pathol 156(6):1103\u20131112","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"3390_CR56","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4274\/tjh.galenos.2020.2020.0348","volume":"38","author":"M Baysal","year":"2021","unstructured":"Baysal M, Umit E, Kirkizlar HO, Demir AM (2021) Comparison of clinical scoring systems in the management of patients with MAHA and thrombocytopenia. Turk J Haematol 38(1):64\u201368","journal-title":"Turk J Haematol"},{"issue":"7","key":"3390_CR57","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1111\/trf.15916","volume":"60","author":"H Moosavi","year":"2020","unstructured":"Moosavi H, Ma Y, Miller MJ, Duncan A (2020) Validation of PLASMIC score: an academic medical centre case series (2012-present). Transfusion 60(7):1536\u20131543","journal-title":"Transfusion"},{"issue":"2","key":"3390_CR58","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/jca.21760","volume":"35","author":"N Zhao","year":"2020","unstructured":"Zhao N, Zhou L, Hu X et al (2020) Modified PLASMIC score including the LDH\/ULN ratio more accurately identifies Chinese TTP patients. J Clin Apher 35(2):79\u201385","journal-title":"J Clin Apher"},{"issue":"2","key":"3390_CR59","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.htct.2018.10.002","volume":"41","author":"DS Oliveira","year":"2019","unstructured":"Oliveira DS, Lima TG, Benevides FLN et al (2019) PLASMIC score applicability for acquired ADAMTS13 deficiency TMA in a developing country. Hematol Transfus Cell Ther 41(2):119\u2013124","journal-title":"Hematol Transfus Cell Ther"},{"key":"3390_CR60","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.thromres.2018.10.010","volume":"172","author":"N Tang","year":"2018","unstructured":"Tang N, Wang X, Li D, Sun Z (2018) Validation of the PLASMIC score for TTP diagnosis in Chinese patients. Thromb Res 172:9\u201313","journal-title":"Thromb Res"},{"issue":"7","key":"3390_CR61","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1182\/bloodadvances.2018017731","volume":"2","author":"A Li","year":"2018","unstructured":"Li A, Khalighi PR, Wu Q, Garcia DA, Padmanabhan A (2018) Evaluation of the PLASMIC score in identifying severe ADAMTS13 deficiency among patients with suspected thrombotic microangiopathy. Blood Adv 2(7):745\u2013754","journal-title":"Blood Adv"},{"issue":"4","key":"3390_CR62","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.transci.2017.06.006","volume":"56","author":"R Jajosky","year":"2017","unstructured":"Jajosky R, Floyd M, Thompson T, Shikle J (2017) Validation of the PLASMIC score at a university medical centre. Transfus Apher Sci 56(4):591\u2013594","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"3390_CR63","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s11239-018-1674-6","volume":"46","author":"GL Tiscia","year":"2018","unstructured":"Tiscia GL, Ostuni A, Cascavilla N et al (2018) Validation of PLASMIC score and follow-up data in patients with suspected microangiopathies from Southern Italy. J Thromb Thrombolysis 46(2):174\u2013179","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"3390_CR64","doi-asserted-by":"publisher","first-page":"251","DOI":"10.4274\/tjh.galenos.2023.2023.0295","volume":"40","author":"M Baysal","year":"2023","unstructured":"Baysal M, Hindilerden F, Umit EG et al (2023) Immune TTP in elderly patients: roles of PLASMIC and French scores. Turk J Haematol 40(4):251\u2013257","journal-title":"Turk J Haematol"},{"issue":"Suppl 2","key":"3390_CR65","first-page":"5","volume":"102","author":"L Fianchi","year":"2017","unstructured":"Fianchi L, Criscuolo M, Lancellotti S et al (2017) Retrospective PLASMIC score application and validation in patients with TTP. Haematologica 102(Suppl 2):5","journal-title":"Haematologica"},{"issue":"5","key":"3390_CR66","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3343\/alm.2023.43.5.485","volume":"43","author":"SH Park","year":"2023","unstructured":"Park SH, Kim HK, Jeong J et al (2023) Performance validation of three scoring systems for TMA due to severe ADAMTS13 deficiency and response to TPE: first study in Korea. Ann Lab Med 43(5):485\u2013492","journal-title":"Ann Lab Med"},{"issue":"3","key":"3390_CR67","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3390\/jcm11030648","volume":"11","author":"L Burguet","year":"2022","unstructured":"Burguet L, Taton B, Prezelin-Reydit M et al (2022) Urine protein\/creatinine ratio in TMAs: a simple test to facilitate TTP and HUS diagnosis. J Clin Med 11(3):648","journal-title":"J Clin Med"},{"issue":"1","key":"3390_CR68","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/trf.16188","volume":"61","author":"A Liu","year":"2021","unstructured":"Liu A, Dhaliwal N, Upreti H, Kasmani J, Dane K, Moliterno A, Braunstein E, Brodsky R, Chaturvedi S (2021) Reduced sensitivity of PLASMIC and French scores for the diagnosis of thrombotic thrombocytopenic purpura in older individuals. Transfusion 61(1):266\u2013273. https:\/\/doi.org\/10.1111\/trf.16188","journal-title":"Transfusion"},{"issue":"3","key":"3390_CR69","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","volume":"158","author":"M Scully","year":"2012","unstructured":"Scully M, Hunt BJ, Benjamin S, Liesner R, Rose P, Peyvandi F et al (2012) Guidelines on the diagnosis and management of TTP and other TMAs. Br J Haematol 158(3):323\u2013335","journal-title":"Br J Haematol"},{"issue":"20","key":"3390_CR70","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1182\/blood-2010-07-271445","volume":"116","author":"JN George","year":"2010","unstructured":"George JN (2010) How I treat patients with thrombotic thrombocytopenic purpura: 2010 update. Blood 116(20):4060\u20134069","journal-title":"Blood"},{"issue":"3","key":"3390_CR71","first-page":"209","volume":"44","author":"JL Winters","year":"2011","unstructured":"Winters JL (2011) Therapeutic plasma exchange in the treatment of thrombotic microangiopathies. Transfus Apher Sci 44(3):209\u2013217","journal-title":"Transfus Apher Sci"},{"key":"3390_CR72","doi-asserted-by":"publisher","first-page":"17020","DOI":"10.1038\/nrdp.2017.20","volume":"3","author":"JA Kremer Hovinga","year":"2017","unstructured":"Kremer Hovinga JA, Coppo P, Lammle B, Moake JL, Miyata T, Tsai HM et al (2017) Thrombotic thrombocytopenic purpura. Nat Rev Dis Primers 3:17020","journal-title":"Nat Rev Dis Primers"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03390-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-026-03390-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03390-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T15:21:11Z","timestamp":1787325671000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-026-03390-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":71,"alternative-id":["3390"],"URL":"https:\/\/doi.org\/10.1007\/s11239-026-03390-5","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"19 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that there is no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}